Property:Funding
This is a property of type Text.
M
Muecke et al. (2014): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization +
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Supported by a grant from the pharmaceutical company biosyn-Arzneimittel GmbH Fellbach, Germany. +
N
Najafizade et al. (2013): Preventive effects of zinc sulfate on taste alterations in patients under irradiation for head and neck cancers: A randomized placebo-controlled trial +
Supported by agrant (project number 290088) from Isfahan University of Medical Sciences. +
Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients +
NI +
Newling et al. (1995): Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group +
Supported by National Cancer Institute, DHHS (Bethesda, Md., USA) +
Ng et al. (2019): Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial +
Supported by grants P50CA127003, R01CA205406, R01CA118553 from the National Institutes of Health, National Cancer Institute; additional funding was provided by the Gloria Spivak Faculty Advancement Award, Friends of Dana-Farber Cancer Institute Award, Project P Fund, Consano, Pharmavite LLC, and Genentech; Pharmavite provided the vitamin D3 and placebo capsules for the study
Funders/ sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation of the manuscript; and decision to submit the manuscript for publication. Pharmavite and Genentech reviewed and approved the manuscript. +
Nguyen et al. (2012): Randomized, Double-Blind, Placebo-Controlled Trial of Polyphenon E in Prostate Cancer Patients before Prostatectomy: Evaluation of Potential Chemopreventive Activities +
Financial support for the study by the National Cancer Institute and the Arizona Cancer Centre +
Niravath et al. (2019): Randomized controlled trial of high‐dose versus standard‐dose vitamin D3 for prevention of aromatase inhibitor‐induced arthralgia +
See conflicts of Interests +
O
Okabayashi et al. (2020): L-Carnitine Improves Postoperative Liver Function in Hepatectomized Patients +
This work was supported by grants from the K ¯ochi Organi-zation for Medical Reformation and Renewal. Dr. TakehiroOkabayashi is the guarantor of this work, had full access to allthe data in the study, and takes responsibility for the integrityof the data and the accuracy of the data analysis. +
Olsen et al. (2001): The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy +
NI +
Ota et al. (2014): The effect of pyridoxine for prevention of hand-foot-syndrome in colorectal cancer patients with adjuvant chemotherapy using capecitabine: A randomized study +
NI +
P
Pace et al. (2003): Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy +
NI +
See Conflicts of Interest. +
Panahi et al. (2012): Effect of Ginger on Acute and Delayed Chemotherapy-Induced Nausea and Vomiting: A Pilot, Randomized, Open-Label Clinical Trial +
This work was financially supported by the Baqiyatallah University of Medical Sciences. +
Paur et al. (2017): Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA +
Supported by Throne Holst Foundation, Research Council of Norway and The Norwegian Cancer Society +
Portenoy et al. (2012): Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial +
Supported in part by the Huntsman Cancer Foundation (S.W.). GW Pharmaceuticals produces nabiximols, which is licensed in Canada as an adjunctive analgesic treatment in adult patients with advanced cancer.
This study was funded by GW Pharmaceuticals and Otsuka. +
Puataweepong et. al (2009): The efficacy of oral Aloe vera juice for radiation induced mucositis in head and neck cancer patients: a double-blind placebo-controlled study +
NI; Verum appears to have been donated by the Faculty of Pharmacy, based on a thank you note to the faculty. +
R
Raei et al. (2013): Effect of herbal therapy to intensity chemotherapy-induced nausea and vomiting in cancer patients +
None declared +
Rao et al. (2014): The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study +
According to information none. +
Raoufinejad et al. (2019): Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial +
Funded through an educational grant to the researchers from the Hematology-Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran +